News 2020-09-18
Porton Received Certificate of Appreciation from Ethiopian Ministry of Health
Recently, Porton Pharma Solutions Ltd has received Certificate of Appreciation from Ethiopian Ministry of Health for Porton’s immense support and outstanding contribution on fighting against COVID-19 with donation of masks. This donation will help healthcare workers in their daily duty in combating the spread of the virus in Ethiopia.
Every company must have a sense of social responsibility, so Porton is willing to contribute its modest and small efforts to show the kindness from China in the ongoing global public health crisis. We will continue to support the global fight against COVID-19.
Others
More
News 2024-10-31
Milestone | Comprehensive Enhancement of GMP Manufacturing Capacity and New Modality Service Capabilities at Porton Fengxian, Shanghai
Recently, Porton Pharma has achieved a significant capacity breakthrough at its GMP manufacturing facility in Fengxian, Shanghai, China, further enhancing its production capabilities and technological strength in new modality areas such as peptide and oligonucleotide drugs. This upgrade represents an important step in Porton's commitment to becoming a leading global CDMO company.
News 2024-10-24
Porton Pharma Solutions Signed Strategic Partnership with Shanghai InnoStar
On October 24, 2024, Porton Pharma SolutionsLtd. ("Porton") announced a strategic partnership with Shanghai InnoStar Bio-tech Co., Ltd. ("InnoStar") in Shanghai. The distinguished signing ceremony was attended by Mr. Ju Nianfeng, Chairman and CEO of Porton; Dr. Chang Yan, President of InnoStar; Ms. Pi Wei, Deputy General Manager of Porton; Ms. Fan Meng, Deputy General Manager of the Sales & Marketing Center, Dr. Fang Xin, Senior Director of Non-clinicalPharmacology BU at InnoStar, and Ms. Zhao Jie, Marketing Associate Director at InnoStar.
